Program Code: SCF-DBI-PECMO-INFECT-0007**
Operational Window: Pre-Cannulation → Active ECMO Support → Decannulation → Recovery → Long-Term Follow-Up
Primary Objective: Prevent infection-mediated recovery failure, preserve immune competence, maintain host–device compatibility, protect endothelial integrity, reduce ECMO-associated sepsis, and optimize long-term recovery outcomes.
SECTION 7.1
CLINICAL POSITIONING
Traditional ECMO Infection Model
Focuses on:
Bloodstream infections
Cannulation site infections
Ventilator-associated infections
Antimicrobial treatment
SCF-DBI ECMO Infection Model
Infection is viewed as:
Host–Circuit–Pathogen Adaptation Failure
resulting in disruption of:
Immune competence
Endothelial stability
Recovery biology
Organ adaptation
Neuroimmune resilience
Core Principle
The optimal ECMO infection program prevents biologic intelligence disruption before overt infection develops.
SECTION 7.2
HOST–CIRCUIT–PATHOGEN INTERACTION INTELLIGENCE MODEL
Domain 1
Host Adaptation
Monitor:
Immune competence
Recovery reserve
Endothelial resilience
Domain 2
Circuit Adaptation
Monitor:
Surface biofilm risk
Circuit duration
Cannulation integrity
Domain 3
Pathogen Adaptation
Monitor:
Colonization pressure
Resistance patterns
Environmental exposure
Domain 4
Recovery Adaptation
Monitor:
Recovery progression
Organ recovery
Functional recovery
Primary Output
Host–Circuit–Pathogen Adaptation Score (HCPAS)
SECTION 7.3
RHENOVA INFECTION PREDICTION ENGINE
Strategic Objective
Forecast infection risk before clinical infection becomes apparent.
Prediction Domains
Module 1
Bloodstream Infection Risk
Module 2
Cannulation Site Infection Risk
Module 3
Ventilator-Associated Infection Risk
Module 4
Device Biofilm Risk
Module 5
Fungal Infection Risk
Module 6
Sepsis Progression Risk
Primary Output
Infection Probability Intelligence Score (IPIS)
SECTION 7.4
ECMO IMMUNE COMPETENCE MONITORING SYSTEM
Clinical Positioning
Immune dysfunction during ECMO may arise from:
Critical illness
Extracorporeal circulation
Transfusion burden
Device exposure
Inflammatory activation
Surveillance Domains
Innate immunity
Adaptive immunity
Self-tolerance
Recovery signaling
Infection resistance
Primary Outputs
STRI
Immune Competence Index (ICI)
SECTION 7.5
ECMO CIRCUIT INFECTION SURVEILLANCE FRAMEWORK
Strategic Objective
Detect circuit-related microbial adaptation before systemic dissemination.
Surveillance Zones
Zone 1
Cannulation interfaces
Zone 2
Tubing systems
Zone 3
Oxygenator system
Zone 4
Access ports
Zone 5
Circuit manipulation points
Monitoring Variables
Temperature trends
Culture surveillance
Inflammatory markers
Circuit integrity
Primary Output
Circuit Biosecurity Score (CBS)
SECTION 7.6
CANNULATION SITE PROTECTION PROGRAM
Clinical Positioning
Cannulation sites represent:
High-Risk Host–Environment Interfaces
Protection Objectives
Preserve tissue integrity
Prevent microbial colonization
Prevent vascular injury
Preserve endothelial recovery
Monitoring Domains
Site appearance
Drainage
Tissue viability
Vascular integrity
Recovery progression
Primary Output
Cannulation Site Integrity Score (CSIS)
SECTION 7.7
BIOFILM PREVENTION FRAMEWORK
Strategic Position
Biofilm formation is viewed as:
Progressive Device Adaptation Failure
Biofilm Risk Factors
Prolonged ECMO duration
Repeated circuit access
Immune dysfunction
High transfusion burden
Monitoring Domains
Circuit age
Manipulation frequency
Culture trends
ICI
Primary Output
Biofilm Vulnerability Index (BVI-ECMO)
SECTION 7.8
ECMO SEPSIS PREVENTION PLATFORM
Clinical Positioning
Sepsis represents:
Systemic Adaptation Failure Syndrome
during ECMO support.
Prevention Domains
Early detection
Immune competence preservation
Endothelial preservation
Organ protection
Recovery preservation
Monitoring Variables
Lactate
STRI
EII
Organ dysfunction markers
IPIS
SECTION 7.9
EARLY SEPSIS RESCUE PATHWAY
Stage I
Threatened Adaptation
Characteristics:
Mild inflammatory activation
Stable organ function
Stage II
Early Sepsis
Characteristics:
Infection confirmed
Early recovery disruption
Stage III
Progressive Sepsis
Characteristics:
Organ dysfunction emerging
ANMS decline
Stage IV
Septic Shock
Characteristics:
Multi-system adaptation failure
Severe endothelial injury
SECTION 7.10
ECMO INFECTION BIOMARKER ATLAS
Infection Burden Biomarkers
CRP
Procalcitonin
Ferritin
White blood cell trends
Endothelial Injury Biomarkers
Syndecan-1
Angiopoietin-2
ICAM-1
VCAM-1
Recovery Biomarkers
STRI
EII
CRIS
ICI
SECTION 7.11
ANMS INFECTION SURVEILLANCE ENGINE
Neuroimmune Domain
Monitor:
Infection burden
Cytokine activation
STRI
Neurovascular Domain
Monitor:
Endothelial injury
EII
Neurocardiac Domain
Monitor:
Perfusion
Lactate
NCRS
Neurometabolic Domain
Monitor:
Energy utilization
Recovery reserve
Neuroendocrine Domain
Monitor:
Stress adaptation
Recovery resilience
Primary Output
Infection-Associated ANMS Score (IAAS)
SECTION 7.12
DAILY ECMO BIOSECURITY ROUNDS
Required Participants
ECMO Intensivist
Infectious Disease Specialist
Perfusion Specialist
Microbiology
Pharmacy
Nursing Leadership
Daily Review
IPIS
ICI
STRI
CBS
CSIS
Recovery trajectory
SECTION 7.13
INFECTION ESCALATION MATRIX
Level 1
Enhanced Monitoring
Triggers:
Mild inflammatory activation
Elevated infection probability
Level 2
Focused Investigation
Triggers:
IPIS increase >15%
ICI decline >10%
Level 3
Multidisciplinary Escalation
Triggers:
Confirmed infection
STRI decline >15%
EII decline >15%
Level 4
Advanced Infection Preservation Activation
Triggers:
Progressive sepsis
Organ dysfunction
IAAS <50
Level 5
Sepsis Rescue Activation
Triggers:
Septic shock
IAAS <40
Progressive multi-organ adaptation failure
SECTION 7.14
LONGITUDINAL IMMUNE RECOVERY SURVEILLANCE
Monitoring Timeline
Decannulation
↓
ICU Discharge
↓
30 Days
↓
90 Days
↓
6 Months
↓
12 Months
Recovery Domains
Immune competence
Infection recurrence
Endothelial recovery
Functional recovery
Neurodevelopmental recovery
SECTION 7.15
INFECTION PREVENTION SUCCESS ENDPOINTS
Clinical
Reduced bloodstream infections
Reduced cannulation infections
Reduced device infections
Reduced sepsis
Recovery
Reduced ICU LOS
Reduced antimicrobial exposure
Improved rehabilitation participation
Biological Intelligence
STRI >80
ICI >80
EII >80
HCPAS >80
IAAS >80
CRIS >80
Sustained immune resilience
PAGE 7 COMPLETION
Next Page (Page 8):